This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Avi Kapoor 8 months ago
NewsInitiationPre-Market OutlookAnalyst RatingsTrading Ideas
Top Wall Street analysts changed outlook on top names. Check out analyst ratings page for all changes. AMLX, OFRM, AGMB, SGP initiated with positive outlook.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Stifel analyst James Condulis initiated coverage on Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) with a Buy rating and announced a price target of $21. Amylyx Pharmaceuticals shares closed at $15.30 on Monday. See how other analysts view this stock.
- Goldman Sachs analyst Leah Jordan initiated coverage on Once Upon A Farm PBC (NYSE:OFRM) with a Buy rating and announced a price target of $43. Once Upon a Farm shares closed at $23.58 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Agomab Therapeutics NV (NASDAQ:AGMB) with an Overweight rating and announced a price target of $28. AgomAb Therapeutics shares closed at $16.21 on Monday. See how other analysts view this stock.
- Stifel analyst Tom Stephan initiated coverage on SpyGlass Pharma, Inc. (NASDAQ:SGP) with a Buy rating and announced a price target of $42. SpyGlass Pharma shares closed at $26.73 on Monday. See how other analysts view this stock.
Considering buying AMLX stock? Here’s what analysts think:
Photo via Shutterstock